Delivery Order SPE2DR25D3012-SPE2DR26F4B7K
Award Date 11/13/25
Potential Completion Date 12/5/25
Potential Value $4.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,343.59 on July 22, 2025, for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. This competitively awarded, firm fixed-price contract is not set aside for any socioeconomic category and is scheduled for completion by August 12, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Tezspire is a specialty biologic medication used in the treatment...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Tezspire 210 mg/1.91 ml pen auto-injectors. This firm fixed-price delivery order, valued at $4,687.18, carries an ultimate completion date of August 21, 2025, and represents a non-competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $11,717.95 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen auto-injectors on September 25, 2025, with an ultimate completion date of October 17, 2025. This firm fixed price, competitively awarded contract—placed with no set-aside designation—represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $2,343.59 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen auto-injectors on September 25, 2025, with an ultimate completion date of October 17, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,687.18 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen auto-injectors on June 9, 2025, with a completion date of July 1, 2025. This firm fixed-price, non-set-aside delivery order represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $14,818.68 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen auto-injectors on November 12, 2025, with a completion date of December 4, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Tezspire is a biologic medication used in the treatment of severe asthma and chronic...
- The Defense Logistics Agency awarded a $14,061.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Tezspire 210 mg/1.91 mL auto-injector pens. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by October 20, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tezspire is a biologic medication used in the treatment of moderate-to-severe...
- The Defense Logistics Agency awarded a delivery order valued at $18,748.72 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen auto-injectors, with an ultimate completion date of October 17, 2025. This competitive, firm fixed-price delivery order was issued under a non-set-aside procurement and performed at the vendor's corporate office in Conshohocken, Pennsylvania. Tezspire is a biologic medication used in the treatment of moderate-to-severe asthma, representing the type of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,687.18 for Tezspire 210 mg/1.91 mL pen injectors, with a completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Tezspire is a specialty biologic medication used in the treatment of severe asthma, representing the type of high-value...
- The Defense Logistics Agency awarded a $4,939.58 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen auto-injectors, with an ultimate completion date of November 12, 2025. This non-set-aside contract represents a firm fixed price delivery order issued on October 21, 2025, and will be performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. Tezspire is a biologic monoclonal antibody treatment used in severe asthma management, reflecting the...